SenseTime Unveils AI-Powered Liver and Cardiac Clinical Solutions at CCR2020 Debut

On November 17, at the 27th National Congress of Radiology of the Chinese Medical Association (CCR2020), a highly influential academic event in the medical community, SenseTime made its debut and prominently launched the SenseCare® Intelligent Clinical Solution for Liver and the SenseCare® Intelligent Clinical Solution for Coronary Artery at the SenseTime Thematic Forum. These two solutions provide AI-assisted interpretation for contrast-enhanced liver CT and coronary CTA images, respectively, helping physicians rapidly locate lesions and offering comprehensive qualitative and quantitative analysis.

Multiple top experts from the medical industry jointly attended this SenseTime-themed forum. Professor Jin Zhengyu, Chairman of the Chinese Society of Radiology and Director of the Department of Radiology at Peking Union Medical College Hospital, stated, “The two solutions launched by SenseTime reflect the inevitable trend of integrating industry, academia, research, and clinical application, and are expected to help physicians address numerous practical clinical challenges.” In addition, Professor Chen Min, Vice Chairman of the Chinese Society of Radiology and Director of the Department of Radiology at Beijing Hospital, expressed hope that SenseTime would continue to deepen its collaboration with radiologists to co-develop more AI applications, ultimately benefiting a broad range of physicians and patients. Professor Hong Nan, Secretary-General of the Chinese Society of Radiology and Assistant to the President as well as Director of the Department of Radiology at Peking University People’s Hospital, also voiced his expectation that these two solutions would provide substantial assistance to clinical diagnosis and treatment.

SenseTime Themed Forum at the Annual Conference of the Chinese Society for Radiation Oncology

Imaging diagnosis plays a pivotal role in the diagnosis and therapeutic efficacy assessment of liver cancer. However, due to the large number of abdominal organs and their complex anatomical structures, physicians often need to switch back and forth among liver images from different phases to conduct comprehensive and precise analysis and diagnosis. In this regard, Professor Song Bin, Deputy Secretary-General of the Chinese Society of Radiology under the Chinese Medical Association and Director of the Department of Radiology at West China Hospital of Sichuan University, also pointed out during the Sensetime thematic forum that liver imaging presents significant challenges to diagnosis and treatment due to factors such as inconsistent scan slice thicknesses, diverse pathological presentations, and the phenomenon where different diseases exhibit similar imaging features. In practice, AI advancements in the field of liver disease diagnosis and treatment have largely remained limited to single-phase imaging and a narrow range of conditions, falling short of the requirements for clinical application.

SenseCare®️ Liver Intelligent Clinical Solution by Sensetime empowers healthcare professionals to leverage AI for the entire diagnostic and therapeutic workflow, from liver image interpretation to preoperative assessment. This solution demonstrates groundbreaking industry advantages through its integrated capabilities in fully automatic multi-phase registration, detection, analysis, and evaluation. It automatically aligns non-contrast and contrast-enhanced multi-phase CT images, precisely detects and segments focal lesions across multiple phases within seconds, and automatically calculates lesion severity and liver surface abnormalities. By providing rich qualitative and quantitative multidimensional analysis, it offers comprehensive assistance to radiologists during image interpretation. Furthermore, the solution features highly stable and smooth real-time rendering of liver structures, tumors, and blood vessels. This reduces the time required for complex 3D reconstruction from one hour to under one minute, enabling surgeons to more thoroughly evaluate surgical plans preoperatively and maximizing the clinical utility of imaging data.

SenseCare®️ Liver Intelligent Clinical Solution by SenseTime Deployed at Sir Run Run Shaw Hospital

Currently, the SenseCare®️ Liver Intelligent Clinical Solution has been deployed at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, seamlessly integrating into physicians’ image interpretation workflows. During the event, Professor Hu Hongjie, Director of the Department of Radiology at the hospital, stated, “Liver imaging diagnosis and treatment involve not only a heavy workload but also significant complexity. The application of AI technology not only reduces repetitive tasks for physicians but, more importantly, provides accurate alerts for key indicators, thereby lowering the risks of missed or misdiagnoses and accelerating the accumulation of clinical experience in liver disease imaging.” Furthermore, this solution has also been implemented at West China Hospital of Sichuan University, where it has pioneered comprehensive, end-to-end imaging management for liver diseases. This advancement better guides the treatment and prognosis of liver cancer patients, offering robust support in combating liver cancer, the fourth leading cause of cancer-related mortality worldwide.

Currently, the prevalence and mortality rates of cardiovascular disease in China remain on an upward trend. “As a critical tool for diagnosing cardiovascular diseases, coronary computed tomography angiography (CTA) has been widely adopted in clinical practice due to its advantages such as convenience, speed, and non-invasiveness,” stated Professor Wang Yining, Deputy Director of the Department of Radiology at Peking Union Medical College Hospital, during the Sensetime-themed forum. However, in current CTA examination workflows, physicians are required to perform complex post-processing reconstruction of CTA images. This reconstruction process demands extensive manual interaction, resulting in reconstruction times exceeding 20 minutes per case, which hampers the efficiency of image interpretation and report generation by physicians.

SenseCare®️, SenseTime’s intelligent clinical solution for cardiac coronary arteries, leverages CTA scan data to automatically perform quantitative grading tasks such as heart segmentation, coronary artery segmentation, centerline extraction, and plaque detection and classification. It offers flexible, interactive visualization of the heart and vessels from any angle using various reconstruction methods. Additionally, it automates film layout and generates structured reports, thereby enhancing physicians’ workflow efficiency through an industry-leading, highly efficient, fully automated process. Professor Wang Yining remarked, “Empowered by AI, the entire CTA workflow has achieved higher-quality, fully automated processing, enabling physicians to make more comprehensive and efficient diagnoses. This truly enhances the capacity for diagnosing and treating cardiovascular diseases in underdeveloped regions and primary healthcare institutions facing shortages of medical resources.”

As one of the first hospitals to implement the SenseCare®️ Intelligent Clinical Solution for Cardiac Coronary Arteries, The Second Affiliated Hospital of Nanjing Medical University (Changzhou No. 2 People's Hospital) has achieved a significant improvement in CTA interpretation efficiency. During the event, Professor Pan Changjie, Director of the Departments of Medical Imaging and Nuclear Medicine at the hospital, stated that previously, diagnosing a single coronary artery case—from image interpretation by physicians to report generation—typically took 15–20 minutes. After integrating this product into the interpretation workflow, the entire process, from data loading to final film printing, now takes only 3–5 minutes. Based on the hospital’s monthly volume of 400–500 coronary artery patients, this translates to nearly 100 hours saved per month, thereby comprehensively enhancing the efficiency of diagnosis and treatment for coronary artery disease and alleviating physicians’ workload.

SenseTime’s SenseCare® Intelligent Clinical Solution for Cardiac Coronary Arteries Deployed at Changzhou No. 2 People’s Hospital

Notably, SenseTime’s SenseCare® Intelligent Diagnosis and Treatment Platform made its comprehensive debut at the recently concluded China International Medical Equipment Fair (CMEF). The launch of two new intelligent auxiliary diagnosis and treatment products has further upgraded the platform’s capabilities, resulting in a solution that covers more than 13 human body parts and organs and features intelligent analysis for multiple diseases. This solution comprehensively meets the needs of radiology departments for image review, analysis, diagnosis, and reporting. By integrating 3D preoperative planning with post-treatment rehabilitation tracking to create a seamless end-to-end workflow, it provides efficient and convenient intelligent assistance to clinicians across multiple specialties, including orthopedics, hepatic surgery, cardiology, pathology, thoracic surgery, and radiation oncology.

Zhang Shaoting, Vice President of SenseTime and Deputy Director of its Research Institute, stated, “Against the backdrop of China’s vigorous development of ‘New Infrastructure,’ AI technology is becoming an engine driving the intelligent transformation of healthcare. The launch of these two innovative clinical solutions demonstrates the phased achievements of SenseTime’s close collaboration with industry experts and top-tier hospitals. By jointly exploring new directions for ‘AI + Healthcare’ in clinical settings, we aim to facilitate the broader adoption of AI applications in clinical practice, thereby optimizing diagnostic and treatment efficiency and enhancing hospital service performance.”

Looking ahead, the SenseCare® Intelligent Diagnosis and Treatment Platform will provide more comprehensive AI-assisted diagnostic capabilities, covering the entire process of diagnosis, treatment, and rehabilitation. On one hand, it will accelerate the integration of expert medical knowledge with AI technology, driving scientific research and innovation in AI healthcare. On the other hand, it will continuously enhance the application value of AI across various clinical scenarios, promoting the transformation of healthcare services from “informatization” to “intelligentization.” This dual-track development of scientific research and clinical application will mutually reinforce each other, making greater contributions to the advancement of human health.

As a globally leading artificial intelligence platform company, SenseTime is the first national next-generation AI open innovation platform designated by China’s Ministry of Science and Technology for “intelligent vision.” Meanwhile, SenseTime is also the AI innovator with the highest total financing amount and valuation worldwide.

SenseTime is driven by the mission and vision of “upholding original innovation to let AI lead human progress.” The company has independently developed and established world-class deep learning platforms and supercomputing centers, launching a series of leading artificial intelligence technologies, including facial recognition, image recognition, text recognition, medical imaging analysis, video analytics, autonomous driving, and remote sensing. SenseTime has become Asia’s largest provider of AI algorithms.

SenseTime holds the leading market share across multiple vertical sectors, with its business spanning smartphones, internet entertainment, automotive, smart cities, as well as industries such as education, healthcare, retail, advertising, finance, and real estate. To date, SenseTime has established partnerships with more than 1,100 renowned enterprises and institutions both in China and abroad, including SNOW, Alibaba, Suning, China Mobile, vivo, Xiaomi, Weibo, Vanke, and Sunac.

SenseTime has established offices in Hong Kong, Shanghai, Beijing, Shenzhen, Chengdu, Hangzhou, Taipei, Kyoto, Tokyo, Singapore, Riyadh, Abu Dhabi, and Dubai. Additionally, the company conducts business in Malaysia, Thailand, Indonesia, South Korea, Macau, and other countries and regions.